Riskpilot← Back to searchSign inGet full accessTampereen Glaukooma Oy
OYActiveY-tunnus 1104797-1Itäinenkatu 3Research and development on medical sciences · NACE 72191Est. 1997— employees
Revenue 2025
EUR 139
-100% vs 2024
EBITDA margin
-2529.5%
-108% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
EUR -4K
-111% vs 2024
| Revenue | EUR 139 | -100% |
| EBITDA | EUR -4K | -108% |
| Net profit | EUR -4K | -111% |
| Total assets | EUR 48K | -23% |
| Equity | EUR 48K | -14% |
| Employees | — | — |
Legal name
Tampereen Glaukooma Oy
Y-tunnus number
1104797-1
Legal form
Osakeyhtiö
NACE code
72191 · Research and development on medical sciences
Founded
21. lokakuuta 1997
Share capital
EUR 8 409
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-05-26
Financial year
January – December
Signatory rights
Selvitystilan aikana selvitysmies yksin
Company purpose
Yhtiön toimialana on harjoittaa lääketieteellistä tutkimus- ja hoitotoimintaa ja tarjota tutkimuspalveluita lääkäreille, muille lääketieteellisen ja sosiaalialan ammattihenkilöille, alan yrityksille ja julkisen puolen toimijoille sekä harjoittaa tutkimuslaitteiden vuokraustoimintaa terveydenhuollon ja sosiaalialan ammattilaisille ja yrityksille. Yhtiö voi omistaa arvopapereita ja kiinteää omaisuutta sekä käydä niillä kauppaa ja saada niistä vuokra- ja muita tuottoja.
Address
Itäinenkatu 3
Phone
+35803313431
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 43 | 43 | 4 223 | 31 | 0 |
| Staff expenses | — | — | −0 | −0 | −0 |
| EBITDA | 27 | 31 | 2 794 | 42 | −4 |
| Depreciation & amort. | −14 | −10 | −779 | −0 | −0 |
| EBIT | 13 | 20 | 2 015 | 42 | −4 |
| Net financials | −1 | −0 | −0 | 0 | −0 |
| Profit before tax | 12 | 20 | 1 995 | 42 | −4 |
| Tax | 2 | 4 | 4 | 8 | −0 |
| Net profit | 10 | 16 | 1 607 | 34 | −4 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 56 | 52 | 36 | 62 | 48 |
| Equity | 32 | 40 | 35 | 56 | 48 |
| Long-term debt | 17 | — | 0 | 0 | 0 |
| Short-term debt | 8 | 12 | 2 | 6 | 0 |
| Total debt | 25 | 12 | 2 | 6 | 0 |
EBITDA margin
-2529.5%
This company
15.8%
Market median
-16109% vs market
20212025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
-7.3%
This company
18.4%
Market median
-140% vs market
20212025
Net profit margin
-2536.7%
This company
8.1%
Market median
-31417% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-05-26
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TA Liquidator | Liquidator | 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Chairperson | 2006 – 2024 | |
| Board of Directors | 2006 – 2024 | |
| Board of Directors | 2006 – 2023 | |
| Board of Directors | 2023 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tampereen Glaukooma Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tero Alberto Minetti | Liquidator | 0 companies |
| Petri Juhani Mäkinen | Chairperson | 0 companies |
| Jorma Seppo Juhani Pietilä | Board of Directors | 0 companies |
| Sirkku Aulikki Pietilä | Board of Directors | 0 companies |
| Hannu Mauno Tapio Uusitalo | Board of Directors | 0 companies |